Madrone Advisors’s Cue Health Inc. Common Stock HLTH Stock Holding History

Madrone Advisors’s Portfolio HLTH Stock Details HLTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,078,566	Closed	-$1.34M	–	7
2024 Q1	$1.34M	Hold	7,078,566	–	–	0.18%	6
2023 Q4	$1.15M	Hold	7,078,566	–	–	0.14%	6
2023 Q3	$3.13M	Hold	7,078,566	–	–	0.67%	8
2023 Q2	$2.61M	Hold	7,078,566	–	–	0.46%	7
2023 Q1	$12.9M	Hold	7,078,566	–	–	2.37%	6
2022 Q4	$14.7M	Buy	+7,078,566	New	+$22.4M	2.83%	6

Other funds holding HLTH

Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return

Oakmont Corp Los Angeles, California $503M AUM 0.36% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

OPTFSNA

Old Point Trust & Financial Services N A Newport News, Virginia $329M AUM 22.88% 1-Year Est. Return

FFA

Frazier Financial Advisors Columbus, Ohio $198M AUM 19.35% 1-Year Est. Return

RFA

Madrone Advisors's HLTH Position: Q2 2024 in Review

Madrone Advisors sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 7,078,566 shares — an estimated $1.34M sold.

Madrone Advisors first reported a position in HLTH in Q4 2022 and held it in 6 quarters. The position peaked at $14.7M in Q4 2022. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

Madrone Advisors reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Madrone Advisors sold 7,078,566 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $1.34M.
Madrone Advisors first reported a position in Cue Health Inc. Common Stock in Q4 2022 and held it in 6 quarters.
Madrone Advisors's Cue Health Inc. Common Stock position peaked at $14.7M in Q4 2022.
9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Madrone Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.